CRP and COVID-19: Both groups showed elevated levels of CRP+ EVs, with 55% (CI 46–61%) and 62% (CI 40–68%) CRP+ EVs in COVID-19 negative and COVID-19 positive patients, respectively, confirming previous results [33], while only 4% (CI 2–4%) of all EVs were associated with CRP in healthy controls.